Advisor Group Holdings, Inc. Codex Dna, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.36 $289 - $401	-170 Reduced 43.04%	225 $0
Q2 2022 Aug 10, 2022	SELL	$1.8 - $6.45 $88 - $316	-49 Reduced 11.04%	395 $0
Q1 2022 May 04, 2022	BUY	$4.12 - $10.36 $889 - $2,237	216 Added 94.74%	444 $2,000
Q3 2021 Nov 05, 2021	BUY	$10.15 - $19.88 $1,806 - $3,538	178 Added 356.0%	228 $3,000
Q2 2021 Aug 02, 2021	BUY	$17.76 - $22.0 $888 - $1,100	50 New	50 $1,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.